EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Diagnostic value of [18F]FDG PET/CT for detection of infectious and inflammatory foci in critically ill patients: a systematic review and meta-analysis

Giorgio Treglia, Domenico Albano, Xavier Wittebole, Andor W J M Glaudemans, Janesh Pillay, Olivier Gheysens iD

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-025-07759-1 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Giorgio Treglia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Critical Illness, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: 2-deoxy-2-[18F]-fluoro-D-glucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) is a hybrid imaging tool increasingly recognized for its effectiveness in evaluating inflammatory and infectious diseases. An emerging application of [18F]FDG PET/CT is the detection of infectious and inflammatory foci in critically ill patients within the intensive care unit (ICU). We performed a systematic review and a diagnostic accuracy meta-analysis to assess the value of [18F]FDG PET/CT in this setting. METHODS: A comprehensive literature search was conducted across PubMed/MEDLINE, Embase, and the Cochrane Library databases, covering studies published up to May 2025. Pooled estimates of sensitivity, specificity, positive and negative likelihood ratios (LR + and LR-), and diagnostic odds ratios (DOR) along with their 95% confidence intervals (95% CI), were calculated. In addition, assessment of publication bias and statistical heterogeneity was conducted. RESULTS: Eight studies (n = 228 patients) were included in the systematic review with seven studies (n = 181 patients) eligible for the meta-analysis. Most contributions of [18F]FDG PET/CT to patient management involved guiding interventional procedures and adjustments to medical therapy such as antimicrobial and corticosteroid treatment. Adverse events related to patient transport or PET/CT scan were not reported in most studies, with exception of one. In terms of diagnostic performance for identifying infectious and inflammatory foci in critically ill patients, the pooled sensitivity, specificity, DOR, LR + and LR − were 91% (95%CI: 80–96), 78% (95%CI: 64–87), 35 (95%CI: 10–121), 4 (95%CI: 2.3–7.1) and 0.12 (0.05–0.28), respectively. No significant statistical heterogeneity or publication bias was detected. CONCLUSION: [18F]FDG PET/CT appears to be a reliable imaging tool for detecting infectious and inflammatory foci in critically ill patients. Its findings have a significant impact on clinical decision-making, particularly in guiding interventional procedures and optimizing medical therapy. However, prospective studies to determine the incidence of findings in a unbiased setting and with use of robust reference standards are warranted to further strengthen and validate the diagnostic value of [18F]FDG PET/CT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Critical IllnessInflammationInfectionsHumans

Stichwörter der Autor:innen

Critically illFDGICUPET/CTPositron emission tomography

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Division of Nuclear Medicine, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
  • Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
  • Division of Nuclear Medicine, ASST Spedali Civili Brescia, Brescia, Italy.
  • Nuclear Medicine Department, University of Brescia, Brescia, Italy.
  • Department of Critical Care Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium.

ORCID-Profile: Olivier Gheysens

Zitieren

APA

Treglia, G., Albano, D., Wittebole, X., Glaudemans, A. W. J. M., Pillay, J., & Gheysens, O. (2026). Diagnostic value of [18F]FDG PET/CT for detection of infectious and inflammatory foci in critically ill patients: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07759-1

Vancouver

Treglia G, Albano D, Wittebole X, Glaudemans AWJM, Pillay J, Gheysens O. Diagnostic value of [18F]FDG PET/CT for detection of infectious and inflammatory foci in critically ill patients: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07759-1

BibTeX
@article{Treglia2026,
  author = {Treglia, Giorgio and Albano, Domenico and Wittebole, Xavier and Glaudemans, Andor W J M and Pillay, Janesh and Gheysens, Olivier},
  title = {Diagnostic value of [18F]FDG PET/CT for detection of infectious and inflammatory foci in critically ill patients: a systematic review and meta-analysis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-025-07759-1}
}
Kostenlos starten →